News
17h
India Today on MSNTirzepatide outperforms semaglutide in clinical trial with faster weight lossA global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...
A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic. For most users, ...
Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.
GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...
5h
Flow Space on MSNCan a GLP-1 Shrink Your Menopause Belly? What New Science Tells UsMenopause can bring more than just hot flashes and mood swings, it can also usher in an expanding waistline that defies diet ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
23h
News-Medical.Net on MSNGLP-1 weight loss drugs leave users low on key nutrients, study findsThis study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...
A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability to ...
Pharma major Biocon says its businesses are at a promising inflection point, with strong momentum expected to continue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results